How Gut Bacteria Turn a Western Diet into Cancer Risk

Picture your colon as a crowded workshop where microbes tinker with chemicals your liver sends downstream. Some of those microbial tinkers are helpful. Others can be troublemakers. What if a typical Western plate — heavy on fat and meat, light on fiber — nudges certain bacteria into producing a compound that nudges gut cells toward cancer?

That provocative idea is at the heart of a new study in Gut, where an international team led by German researchers stitched together experiments in genetically altered pigs and mice, lab-grown human colon tissue, and microbial analyses from more than two thousand people to trace a plausible chain of events from diet to tumor growth.

The chemistry center of attention is deoxycholic acid, or DCA. Bile acids start life in the liver as molecules that emulsify fats; most get recycled before ever reaching the colon. But a small fraction drifts into the large intestine, where a subset of bacteria perform a specialized reaction — 7-alpha-dehydroxylation — converting primary bile acids into secondary ones like DCA. Think of these microbes as chemical alchemists: the wrong reaction, in the wrong place, can produce a harmful brew.

Colorectal cancer is the third most common cancer worldwide and is increasingly affecting young people. 

In pigs genetically prone to forming colon polyps, swapping their normal chow for a Western-style diet made tumors worse. Fecal DCA levels rose. The epithelial cells that line the colon began to proliferate excessively. Then the researchers added an old-school drug to the mix, cholestyramine, which binds bile acids in the gut so they are flushed away. Remove the bile acids, and the runaway cell growth cooled off. Causation—at least in this model—looked more credible.

To tighten the causal chain, the team used germ-free mice, animals whose gut microbiome can be assembled like a playlist. Introducing DCA-producing species such as Clostridium scindens and Extibacter muris into defined microbial communities led to DCA production and, crucially, to more colon tumors across two mouse cancer models. In a clever reverse experiment, scientists crippled the bile-transforming gene in a bacterium called Faecalicatena contorta. Mice carrying the engineered strain developed fewer tumors, and human colon organoids exposed to the altered bug showed less epithelial hyperproliferation.

Those animal and lab results were then mapped back to people. The researchers analyzed stool-derived microbial DNA from cohorts totaling 1,034 individuals with colorectal cancer and 1,108 controls. Genes associated with DCA production, particularly those tied to C. scindens and similar species, appeared more often in people with colorectal cancer than in those without.

The foods we eat can affect our gut microbiome, with flow-on effects to our health. 

This chain — Western diet changes, bacterial bile conversion to DCA, and DCA-driven epithelial proliferation — offers a plausible biological link between what we eat and the risk of colorectal cancer.

Important caveats remain. The animal work used models already predisposed to the disease, and the human portion was observational, meaning it can pinpoint associations but cannot prove that microbial DCA caused cancer in those people. The cholestyramine experiments are suggestive, not prescriptive: they do not demonstrate that bile acid-binding drugs prevent cancer in humans. Clinical trials would be required before any treatment claims could be made.

Still, the study stitches together multiple lines of evidence in a way that few single-model papers can. It moves the conversation past correlation and toward mechanism: a Western-style diet alters bile acid dynamics and selects for microbes that make DCA, and DCA, in turn, appears capable of stimulating abnormal cell behavior that primes the colon for tumor growth.

What does this mean for everyday life? For now, the findings reinforce long-standing dietary guidance rather than upend it. Diets rich in fiber, fruits, vegetables and whole grains and lower in processed and red meats are consistently associated with lower colorectal cancer risk. The new work also opens an intriguing possibility for future screening: microbiome profiles might help identify people whose guts convert bile acids into potentially harmful molecules more readily, making them more vulnerable to diet-driven risk.

Researchers must now test whether targeting microbial bile chemistry can prevent cancer in people, and whether interventions — dietary, pharmacological, or microbial — can safely and effectively shift that chemistry. Until those trials arrive, the simplest practical step remains old-fashioned: eat more plants, less processed fare, and give your gut ecosystem a fighting chance to stay on the helpful side of chemistry.